X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

IMMUNOLOGICAL INVESTIGATIONS

期刊標題檢索 IMMUNOL INVEST 最新評論: Review Speed: 1.0 | Submission Hit Rate: 95.0 Research focus: Aut... (2024-08-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[IMMUNOLOGICAL INVESTIGATIONS]您好,您是該頁面的第 20894 位訪客。

期刊簡介
期刊名稱IMMUNOLOGICAL INVESTIGATIONS IMMUNOLOGICAL INVESTIGATIONS
LetPub Score
6.1
50 ratings
Rate

Reputation
7.4

Influence
4.9

Speed
7.0

期刊簡稱IMMUNOL INVEST
ISSN0882-0139
E-ISSN1532-4311
h-index42
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.500.6540.552
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: Immunology
Q3129 / 236

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Disseminating immunological developments on a worldwide basis, Immunological Investigations encompasses all facets of fundamental and applied immunology, including immunohematology and the study of allergies. This journal provides information presented in the form of original research articles and book reviews, giving a truly in-depth examination of the latest advances in molecular and cellular immunology.
官方網站http://www.tandfonline.com/toc/iimm20/current
在線稿件提交https://mc.manuscriptcentral.com/limm
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年0
每年文章數60每年文章數趨勢
黃金OA百分比6.53%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ3108/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0882-0139%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【IMMUNOLOGICAL INVESTIGATIONS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology337412
    JOURNAL OF IMMUNOLOGY156801
    Immunity108117
    Cellular & Molecular Immunology107572
    Vaccine104880
    JOURNAL OF EXPERIMENTAL MEDICINE99619
    MICROBIAL PATHOGENESIS94357
    MOLECULAR IMMUNOLOGY91239
    INFLAMMATION89894
    BRAIN BEHAVIOR AND IMMUNITY84922
  •  

    IMMUNOLOGICAL INVESTIGATIONS IMMUNOLOGICAL INVESTIGATIONS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [IMMUNOLOGICAL INVESTIGATIONS] 的評論撰寫評論
作者: 寂灭慕梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-28 18:38:09 評論於
Review Speed: 1.0 | Submission Hit Rate: 95.0 
Research focus: Autoimmune diseases; Inflammation 
Experience sharing: Submitted on March 22, 2024 
With Editor on March 24, 2024 
Out for Review on April 24, 2024 
Revision Required on July 10, 2024 
Revision Incomplete on July 10, 2024 
Revised Manuscript Submitted on July 15, 2024 
With Editor on July 15, 2024 
Out for Review on August 11, 2024 
Accepted: The acceptance and publication process took about half a month and was very detailed. It is relatively easy to get published, suitable for graduation articles.
(0) 讚! | 寂灭慕梅

作者: 寂灭慕梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 19:46:58 評論於
His APC is very expensive, it's already 26,000 yuan.
(0) 讚! | 寂灭慕梅

作者: 寂灭慕梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-12 19:51:49 評論於
Manual input, then there will be options to choose from.
(0) 讚! | 寂灭慕梅

作者: 岳家婉清


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-22 16:47:05 評論於
Why can't departments and organizations make choices?
(0) 讚! | 岳家婉清

作者: 龙鳞奕洳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 23:01:02 評論於
Review speed: 3.0 | Submission hit rate: 75.0
Emphasized research direction: Immunology; Osteoarthritis
Experience sharing: The editorial process took one week to be sent for review, and the revisions were completed in two weeks by external reviewers. Acceptance was granted after nearly four months of the second review
(0) 讚! | 龙鳞奕洳

作者: 雨巷少年怿悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-26 19:24:41 評論於
How long did it take you to finish?
(0) 讚! | 雨巷少年怿悦

作者: 树行小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-05 17:39:19 評論於
Has your article been published? How long does it take from submission to acceptance?
(0) 讚! | 树行小姐姐

作者: 京城统勋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-11 19:19:35 評論於
How long does it usually take from receiving the proof to the final design?
(0) 讚! | 京城统勋

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:48:12 評論於
Manuscript of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:27:30 評論於
Currently ORCID is optional, not mandatory. However, it is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researches related to their publications to use an ORCID iD.
19. How to add an ORCID ID if the article has been published without it?
ORCID stands for Open Researcher and Contributor ID. ORCID iD is a unique and persistent academic identity for contributors, allowing authors to be distinguished from other researchers and keeping a record of all their related research activities. To add an ORCID iD for an article that has already been published, you will need to log in to the account of each author and associate the ORCID iD in the account information settings
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 11:25:38 評論於
Is it necessary to provide the ORCID ID of each author when submitting a manuscript?
(0) 讚! | Darlene Pepys

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:37:06 評論於
What is MS?
(0) 讚! | 平原文波

作者: 猫巷少女逸思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-27 09:33:25 評論於
Just submitted my application, hoping to be accepted
(0) 讚! | 猫巷少女逸思

作者: 平原映云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-06 13:55:51 評論於
How long does it generally take from acceptance to publication?
(0) 讚! | 平原映云

作者: alsahebfosoul@med.mui.ac.ir


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-03 09:04:39 評論於
Effect of Fingolimod on the frequency of regulatory T cells in patients with relapsing-remitting multiple sclerosis.
ID is LIMM-2018-0117.
(0) 讚! | alsahebfosoul@med.mui.ac.ir

作者: alsahebfosoul@med.mui.ac.ir


領域: 医药科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2018-08-03 09:04:26 評論於
Effect of Fingolimod on the frequency of regulatory T cells in patients with relapsing-remitting multiple sclerosis.ID is LIMM-2018-0117.

(0) 讚! | alsahebfosoul@med.mui.ac.ir

作者: 桃花觅风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-28 18:41:35 評論於
Around one month
Huihui 2016-05-28 Posted: SCI(2014):1.991 Why hasn't anyone written about their experiences? How long does the first review take?
(0) 讚! | 桃花觅风

作者: 子童姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-05-28 15:19:40 評論於
Why is nobody writing their experiences? How long does the first review take?
(0) 讚! | 子童姑娘

作者: Theresa Edward


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-11-09 19:57:29 評論於
Review Speed: 3.0 | Submission Success Rate: 50.0
Experience Share: Submitted online for half a year
(0) 讚! | Theresa Edward

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [IMMUNOLOGICAL INVESTIGATIONS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*